Increasingly there is a trend towards implementation of Mobile & Process Analytical
Technology (PAT) in development and production across a variety of industries. These
technologies enable real time analysis, providing significant value through enhancing
process understanding, speed and efficiency, and help facilitate process optimisation and
reduced costs.
Agilent has been working closely with industry partners to offer a variety of analytical
solutions specifically designed to address industry needs.
The principle behind the PAT is to enhance process and product understanding, and
process control. This will help to ensure the desired final product quality with the use of
statistical techniques to establish a design space. The implementation of PAT systems in
the pharmaceutical/biopharma industry is derived from the regulatory authorities’
initiatives to improve and modernize the industry. This shall enhance product quality with
the adaptation of quality by design (QbD)/PAT concepts. The common theme of the QbD
philosophy is to build quality into the products instead of testing the product to ensure
quality.
QbD/PAT-enabled control strategies ensure the development of robust and efficient
bioprocesses to deliver high quality drugs with desired product quality and batch-to-batch
reproducibility.
With a focus on chromatographic and spectroscopy-based solutions, we invite you to join
us, together with Repligen and other industry experts, to learn more about the latest
exciting developments in the field of mobile & PAT testing, including:
• Transforming raw material QC analysis – increasing throughput without increasing
cost using novel Raman solutions
• How new LC developments support Online Reaction Monitoring
• Using Handheld FTIR for measurement of surface contamination
• Increase Overall GMP Operational Efficiencies with dilution-free concentration
measurement – Dean Barton, Repligen
Attendance is free, however registration is required. Registration for both sessions is now
open!
